Objectives: The aim of this work is to compare the results of the management of the USG with methotrexate medical treatment and laparoscopy at the "G" Point CHU. Patients and Method: This was a descriptive retrospective study over five years (January 2010 to December 2014) in the General and Laparoscopic Surgery Department and the Obstetrics and Gynecology Department of the Point "G" UHC. Patients treated for tubal location GEU were included either by medical treatment with methotrexate or laparoscopy Results: The clinical records of 61 patients were collected and divided into two groups: a medical treatment group (GM) with 29 patients and a laparoscopy group (CG) with 32 patients. UEM accounted for 1.8% of obstetric emergencies in GM and 2.2% of laparoscopic surgery activities in the GC. The average age of patients in both groups was 32.3 years with extremes of 16 years and 42 years. The amenorrhea triad pelvic pain and metrorrhagia was found in 42% in the GC and 22% in the GM. Uncomplicated haematosalpinx was observed in 82.7% in GM vs 40.6% in GC. Failure of medical treatment was observed in 31%. Salpingectomy for laparoscopic surgery was performed in 6.3%. The return to fertility was observed in 15.4% in GM including 10.4% term pregnancies and 5% recidivism vs. 25% in the GC with 15.6% term pregnancies and 9.3% recidivism. Mortality was zero in both groups. Conclusion: Both methods are feasible and reproducible in the context of working at the "G" Point Hospital Center at the cost of respect for the indications, each having proved its advantages and its limits.